Identification of Potential Biomarkers of Peptide Immunotherapy. Part 1 - Proteomics Analysis
Phase of Trial: Phase I
Latest Information Update: 23 Apr 2015
At a glance
- Drugs Cat SPIRE (Primary)
- Indications Allergic rhinitis; Hypersensitivity; Rhinoconjunctivitis
- Focus Biomarker; Pharmacodynamics
- Sponsors Circassia
- 24 Feb 2014 Status changed from active, no longer recruiting to completed according to ClinicalTrials.gov record.
- 17 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 28 Jan 2013 Planned End Date changed from 1 Dec 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.